key: cord-0813029-p4ndznia
authors: Pena Orbea, Cinthya; Wang, Lu; Shah, Vaishal; Jehi, Lara; Milinovich, Alex; Foldvary-Schaefer, Nancy; Chung, Mina K.; Mashaqi, Saif; Aboussouan, Loutfi; Seidel, Kelsey; Mehra, Reena
title: Association of Sleep-Related Hypoxia With Risk of COVID-19 Hospitalizations and Mortality in a Large Integrated Health System
date: 2021-11-10
journal: JAMA Netw Open
DOI: 10.1001/jamanetworkopen.2021.34241
sha: 82949c9f3c0268716db483015bd2d005e70aefbc
doc_id: 813029
cord_uid: p4ndznia

IMPORTANCE: The influence of sleep-disordered breathing (SDB) and sleep-related hypoxemia in SARS-CoV-2 viral infection and COVID-19 outcomes remains unknown. Controversy exists regarding whether to continue treatment for SDB with positive airway pressure given concern for aerosolization with limited data to inform professional society recommendations. OBJECTIVE: To investigate the association of SDB (identified via polysomnogram) and sleep-related hypoxia with (1) SARS-CoV-2 positivity and (2) World Health Organization (WHO)-designated COVID-19 clinical outcomes while accounting for confounding including obesity, underlying cardiopulmonary disease, cancer, and smoking history. DESIGN, SETTING, AND PARTICIPANTS: This case-control study was conducted within the Cleveland Clinic Health System (Ohio and Florida) and included all patients who were tested for COVID-19 between March 8 and November 30, 2020, and who had an available sleep study record. Sleep indices and SARS-CoV-2 positivity were assessed with overlap propensity score weighting, and COVID-19 clinical outcomes were assessed using the institutional registry. EXPOSURES: Sleep study–identified SDB (defined by frequency of apneas and hypopneas using the Apnea-Hypopnea Index [AHI]) and sleep-related hypoxemia (percentage of total sleep time at <90% oxygen saturation [TST <90]). MAIN OUTCOMES AND MEASURES: Outcomes were SARS-CoV-2 infection and WHO-designated COVID-19 clinical outcomes (hospitalization, use of supplemental oxygen, noninvasive ventilation, mechanical ventilation or extracorporeal membrane oxygenation, and death). RESULTS: Of 350 710 individuals tested for SARS-CoV-2, 5402 (mean [SD] age, 56.4 [14.5] years; 3005 women [55.6%]) had a prior sleep study, of whom 1935 (35.8%) tested positive for SARS-CoV-2. Of the 5402 participants, 1696 were Black (31.4%), 3259 were White (60.3%), and 822 were of other race or ethnicity (15.2%). Patients who were positive vs negative for SARS-CoV-2 had a higher AHI score (median, 16.2 events/h [IQR, 6.1-39.5 events/h] vs 13.6 events/h [IQR, 5.5-33.6 events/h]; P < .001) and increased TST <90 (median, 1.8% sleep time [IQR, 0.10%-12.8% sleep time] vs 1.4% sleep time [IQR, 0.10%-10.8% sleep time]; P = .02). After overlap propensity score–weighted logistic regression, no SDB measures were associated with SARS-CoV-2 positivity. Median TST <90 was associated with the WHO-designated COVID-19 ordinal clinical outcome scale (adjusted odds ratio, 1.39; 95% CI, 1.10-1.74; P = .005). Time-to-event analyses showed sleep-related hypoxia associated with a 31% higher rate of hospitalization and mortality (adjusted hazard ratio, 1.31; 95% CI, 1.08-1.57; P = .005). CONCLUSIONS AND RELEVANCE: In this case-control study, SDB and sleep-related hypoxia were not associated with increased SARS-CoV-2 positivity; however, once patients were infected with SARS-CoV-2, sleep-related hypoxia was an associated risk factor for detrimental COVID-19 outcomes.

Mediation analysis was performed on the subgroup of patients who had blood sample of C-reactive protein (CRP) on admission. The dependent variable was the dichotomized outcome of high-level WHO-7 COVID-19 scale (any Supplemental Oxygen, High flow/Noninvasive mechanical ventilation, ECMO/Invasive mechanical ventilation, or Death). CRP was assumed to have mediation effect in the causal pathway between high-level WHO-7 COVID-19 scale and sleep indices. To satisfy normal distribution assumption, logarithm transformation was used on CRP. Both outcome model and mediator model were adjusted for demographics, comorbidities, smoking pack year and clinic site. Natural indirect effect was estimated by using PROC CAUSALMED statement in SAS software (version 9.4, Cary, NC).

To assess the mediation effect of CRP (M), the first step was testing relationships between sleep indices (T) and the outcome (Y). If T -> Y is significant, we require significant relationship between CRP and sleep indices (T -> M). Then, the mediation effect, or natural indirect effect, was estimated by a logistic regression model of Y, with both T and M in the model, and comparing with the first model (T -> Y). Based on e- 

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

Extracting and utilizing electronic health data from Epic for research

The REDCap consortium: Building an international community of software platform partners

Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support

Nocturnal intermittent hypoxia and C reactive protein among middle-aged community residents: A cross-sectional survey

Clinical course of COVID-19 patients needing supplemental oxygen outside the intensive care unit